Lan Zhao

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Pulmonary Arterial Hypertension

Polycyclic Aromatic Hydrocarbons

Sickle Cell Disease

Top Venues

The European respiratory journal

Annals of the American Thoracic Society

Circulation research

This page only lists publications with an associated author ORCID identifier.

Publications

Fu-Chiang Yeh, Chien-Nien Chen, Chong-Yang Xie, Nicoleta Baxan, Lin Zhao, Ali Ashek, Farah Sabrin, Allan Lawrie, Martin R Wilkins, Lan Zhao
TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension. The European respiratory journal (2023)
Chinthaka B Samaranayake, Aleksander Kempny, Robert Naeije, Michael Gatzoulis, Laura C Price, Konstantinos Dimopoulos, Lan Zhao, Stephen J Wort, Colm McCabe
Beta-blockade improves right ventricular diastolic function in exercising pulmonary arterial hypertension. The European respiratory journal (2023)
Rachel Walters, Eleni Vasilaki, Jurjan Aman, Chien-Nien Chen, Yukyee Wu, Olin D Liang, Ali Ashek, Olivier Dubois, Lin Zhao, Farah Sabrin, Inês Cebola, Jorge Ferrer, Nicholas W Morrell, James R Klinger, Martin R Wilkins, Lan Zhao, Christopher J Rhodes
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. Circulation (2023)
Hannah Knight, Giancarlo Abis, Manpreet Kaur, Hannah L H Green, Susanne Krasemann, Kristin Hartmann, Steven Lynham, James E Clark, Lan Zhao, Clemens Ruppert, Astrid Weiss, Ralph Theo Schermuly, Philip Eaton, Olena Rudyk
Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation. Circulation research (2023)
Rachel Walters, Eleni Vasilaki, Martin R Wilkins, Lan Zhao, Christopher J Rhodes
Response by Walters et al to Letter Regarding Article, " SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension". Circulation 148 (22) (2023)
Chien-Nien Chen, Nabil Hajji, Fu-Chiang Yeh, Sunniyat Rahman, Souad Ali, John Wharton, Nicoleta Baxan, Lin Zhao, Chong-Yang Xie, Yi-Guan Chen, Maria G Frid, Prakash Chelladurai, Soni Savai Pullamsetti, Kurt R Stenmark, Martin R Wilkins, Lan Zhao
Restoration of Foxp3 + Regulatory T Cells by HDAC-dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology. American journal of respiratory and critical care medicine (2023)
Luke S G E Howard, Jianguo He, Geoffrey M J Watson, Li Huang, John Wharton, Qin Luo, David G Kiely, Robin Condliffe, Joanna Pepke-Zaba, Nicholas W Morrell, Karen K Sheares, Anna Ulrich, Ruilin Quan, Zhihui Zhao, Xiaoli Jing, Chenhong An, Zhihong Liu, Changming Xiong, Peter A Robbins, Timothy Dawes, Antonio de Marvao, Christopher J Rhodes, Manuel J Richter, Henning Gall, Hossein A Ghofrani, Lan Zhao, Les Huson, Martin R Wilkins
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials. Annals of the American Thoracic Society 18 (6) (2021)
Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R Wilkins, Christopher J Rhodes
The pathophysiological role of novel pulmonary arterial hypertension gene SOX17. The European respiratory journal 58 (3) (2021)
Evangelos D Michelakis, Vikram Gurtu, Linda Webster, Gareth Barnes, Geoffrey Watson, Luke S G Howard, John Cupitt, Ian Paterson, Richard B Thompson, Kelvin Chow, Declan P O'Regan, Lan Zhao, John Wharton, David G Kiely, Adam Kinnaird, Aristeidis E Boukouris, Chris White, Jayan Nagendran, Darren H Freed, Stephen J Wort, J Simon R Gibbs, Martin R Wilkins
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. Science translational medicine 9 (413) (2018)